Unknown

Dataset Information

0

Molecular Analysis of Spinal Muscular Atrophy: A genotyping protocol based on TaqMan(®) real-time PCR.

ABSTRACT: Spinal muscular atrophy (SMA) is an autosomal recessive inherited disorder caused by alterations in the survival motor neuron I (SMN1) gene. SMA patients are classified as type I-IV based on severity of symptoms and age of onset. About 95% of SMA cases are caused by the homozygous absence of SMN1 due to gene deletion or conversion into SMN2. PCR-based methods have been widely used in genetic testing for SMA. In this work, we introduce a new approach based on TaqMan(®)real-time PCR for research and diagnostic settings. DNA samples from 100 individuals with clinical signs and symptoms suggestive of SMA were analyzed. Mutant DNA samples as well as controls were confirmed by DNA sequencing. We detected 58 SMA cases (58.0%) by showing deletion of SMN1 exon 7. Considering clinical information available from 56 of them, the patient distribution was 26 (46.4%) SMA type I, 16 (28.6%) SMA type II and 14 (25.0%) SMA type III. Results generated by the new method was confirmed by PCR-RFLP and by DNA sequencing when required. In conclusion, a protocol based on real-time PCR was shown to be effective and specific for molecular analysis of SMA patients.

SUBMITTER: de Souza Godinho FM 

PROVIDER: S-EPMC3571419 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Molecular Analysis of Spinal Muscular Atrophy: A genotyping protocol based on TaqMan(®) real-time PCR.

de Souza Godinho Fernanda Marques FM   Bock Hugo H   Gheno Tailise Conte TC   Saraiva-Pereira Maria Luiza ML  

Genetics and molecular biology 20121218 4 (suppl)

Spinal muscular atrophy (SMA) is an autosomal recessive inherited disorder caused by alterations in the survival motor neuron I (SMN1) gene. SMA patients are classified as type I-IV based on severity of symptoms and age of onset. About 95% of SMA cases are caused by the homozygous absence of SMN1 due to gene deletion or conversion into SMN2. PCR-based methods have been widely used in genetic testing for SMA. In this work, we introduce a new approach based on TaqMan(®)real-time PCR for research a  ...[more]

Similar Datasets

Unknown New multiplex real-time PCR approach to detect gene mutations for spinal muscular atrophy.
| S-EPMC4989483 | biostudies-literature
Unknown Detection of Spinal Muscular Atrophy Using a Duplexed Real-Time PCR Approach With Locked Nucleic Acid-Modified Primers.
| S-EPMC7443528 | biostudies-literature
Unknown Novel method for genotyping hepatitis B virus on the basis of TaqMan real-time PCR.
| S-EPMC2849621 | biostudies-literature
Unknown Newborn Screening for 5q Spinal Muscular Atrophy: Comparisons between Real-Time PCR Methodologies and Cost Estimations for Future Implementation Programs.
| S-EPMC8396021 | biostudies-literature
Unknown Real-time PCR genotyping using displacing probes.
| S-EPMC407835 | biostudies-other
Unknown Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency.
| S-EPMC7906865 | biostudies-literature
Unknown Spinal muscular atrophy.
| S-EPMC4514700 | biostudies-other
Unknown A National Spinal Muscular Atrophy Registry for Real-World Evidence.
| S-EPMC7656664 | biostudies-literature
Unknown An updated TaqMan real-time PCR for canine and feline parvoviruses.
| S-EPMC7119788 | biostudies-literature
Unknown Rapid diagnosis of sepsis with TaqMan-Based multiplex real-time PCR.
| S-EPMC6816908 | biostudies-literature